Bray, F. et al. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127, 3029–3030 (2021).
Google Scholar
Meijers, R. A. & de Boer, R. A. Common risk factors for heart failure and cancer. Cardiovasc. Res. 115, 844–853 (2019).
Google Scholar
de Boer, R. A. et al. Cancer and heart disease: associations and relations. Eur. J. Heart Fail. 21, 1515–1525 (2019).
Google Scholar
Koene, R. J. et al. Shared risk factors in cardiovascular disease and cancer. Circulation 133, 1104–1114 (2016).
Google Scholar
Stoltzfus, K. C. et al. Fatal heart disease among cancer patients. Nat. Commun. 11, 2020 (2011).
Battisti, N. M. L. et al. Prevalence of cardiovascular disease in patients with potentially curable malignancies: a national registry dataset analysis. JACC CardioOncol. 4, 238–253 (2022).
Google Scholar
Florido, R. et al. Cardiovascular disease risk among cancer survivors: the Atherosclerosis Risk in Communities (ARIC) study. J. Am. Coll. Cardiol. 80, 22–32 (2022).
Google Scholar
Paterson, D. I. et al. Incident cardiovascular disease among adults with cancer. JACC CardioOncol. 4, 85–94 (2022).
Google Scholar
Zhang, X. et al. Ten-year cardiovascular risk among cancer survivors: the National Health and Nutrition Examination Survey. PLoS ONE 16, e0247919 (2021).
Google Scholar
Aboumsallem, J. P., Moslehi, J. & de Boer, R. A. Reverse cardio-oncology: cancer development in patients with cardiovascular disease. J. Am. Heart Assoc. 9, e013754 (2020).
Google Scholar
Bell, C. F. et al. Risk of cancer after diagnosis of cardiovascular disease. JACC CardioOncol. 5, 431–440 (2023).
Google Scholar
Chianca, M. et al. Bidirectional relationship between cancer and heart failure: insights on circulating biomarkers. Front. Cardiovasc. Med. 9, 936654 (2022).
Google Scholar
Hayek, S. S. et al. Preparing the cardiovascular workforce to care for oncology patients: JACC review topic of the week. J. Am. Coll. Cardiol. 73, 2226–2235 (2019).
Google Scholar
Herrmann, J. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat. Rev. Cardiol. 17, 474–502 (2020).
Google Scholar
Herrmann, J. Vascular toxic effects of cancer therapies. Nat. Rev. Cardiol. 17, 503–522 (2020).
Google Scholar
Omland, T., Heck, S. L. & Gulati, G. The role of cardioprotection in cancer therapy cardiotoxicity. JACC CardioOncol. 4, 19–37 (2022).
Google Scholar
Tan, S. et al. Immune checkpoint inhibitor therapy in oncology. JACC CardioOncol. 4, 579–597 (2022).
Google Scholar
Quartermaine, C. et al. Cardiovascular toxicities of BTK inhibitors in chronic lymphocytic leukemia. JACC CardioOncol. 5, 570–590 (2023).
Google Scholar
Glen, C. et al. Mechanistic and clinical overview cardiovascular toxicity of BRAF and MEK inhibitors: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 4, 1–18 (2022).
Google Scholar
Parashar, S. et al. Cancer treatment-related cardiovascular toxicity in gynecologic malignancies. JACC CardioOncol. 5, 159–173 (2023).
Google Scholar
Welty, N. E. & Gill, S. I. Cancer immunotherapy beyond checkpoint blockade. JACC CardioOncol. 4, 563–578 (2022).
Google Scholar
Georgiopoulos, G. et al. Cardiovascular toxicity of proteasome inhibitors: underlying mechanisms and management strategies: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 5, 1–21 (2023).
Google Scholar
Bergom, C. et al. Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification. JACC CardioOncol. 3, 343–359 (2021).
Google Scholar
de Boer, R. A. et al. Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur. J. Heart Fail. 22, 2272–2289 (2020).
Google Scholar
Karlstaedt, A., Moslehi, J. & de Boer, R. A. Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer. Nat. Rev. Cardiol. 19, 414–425 (2022).
Google Scholar
Leiva, O. et al. Common pathophysiology in cancer, atrial fibrillation, atherosclerosis, and thrombosis: JACC: CardioOncology state-of-the-art review. JACC CardioOncol. 3, 619–634 (2021).
Google Scholar
Fuchs, F. D. & Whelton, P. K. High blood pressure and cardiovascular disease. Hypertension 75, 285–292 (2020).
Google Scholar
Cohen, J. B. et al. Hypertension in cancer patients and survivors. JACC CardioOncol. 1, 238–251 (2019).
Google Scholar
Lewington, S. et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913 (2002).
Google Scholar
Rahimi, K. et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet 397, 1625–1636 (2021).
Google Scholar
Ettehad, D. et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387, 957–967 (2016).
Google Scholar
Seretis, A. et al. Association between blood pressure and risk of cancer development: a systematic review and meta-analysis of observational studies. Sci. Rep. 9, 8565 (2019).
Google Scholar
Harding, J. L. et al. Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts. J. Hypertens. 34, 149–155 (2016).
Google Scholar
Han, H. et al. Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci. Rep. 7, 44877 (2017).
Google Scholar
Nelson, R. H. Hyperlipidemia as a risk factor for cardiovascular disease. Prim. Care 40, 195–211 (2013).
Google Scholar
Borén, J. et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur. Heart J. 41, 2313–2330 (2020).
Google Scholar
Google Scholar
Navarese, E. P. et al. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis. JAMA 319, 1566–1579 (2018).
Google Scholar
Yao, X. & Tian, Z. Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies. Cancer Causes Control 26, 257–268 (2015).
Google Scholar
Yuan, F. et al. Serum lipid profiles and cholesterol-lowering medication use in relation to subsequent risk of colorectal cancer in the UK Biobank cohort. Cancer Epidemiol. Biomark. Prev. 32, 524–530 (2023).
Google Scholar
Fang, Z., He, M. & Song, M. Serum lipid profiles and risk of colorectal cancer: a prospective cohort study in the UK Biobank. Br. J. Cancer 124, 663–670 (2021).
Google Scholar
Tian, Y. et al. The association between serum lipids and colorectal neoplasm: a systemic review and meta-analysis. Public Health Nutr. 18, 3355–3370 (2015).
Google Scholar
Nouri, M. et al. Effect of serum lipid profile on the risk of breast cancer: systematic review and meta-analysis of 1,628,871 women. J. Clin. Med. 11, 4503 (2022).
Google Scholar
Ni, H., Liu, H. & Gao, R. Serum lipids and breast cancer risk: a meta-analysis of prospective cohort studies. PLoS ONE 10, e0142669 (2015).
Google Scholar
Nowak, C. & Ärnlöv, J. A Mendelian randomization study of the effects of blood lipids on breast cancer risk. Nat. Commun. 9, 3957 (2018).
Google Scholar
Ganjali, S. et al. HDL and cancer – causality still needs to be confirmed? Update 2020. Semin. Cancer Biol. 73, 169–177 (2021).
Google Scholar
Pirro, M. et al. High density lipoprotein cholesterol and cancer: marker or causative? Prog. Lipid Res. 71, 54–69 (2018).
Google Scholar
Powell-Wiley, T. M. et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 143, e984–e1010 (2021).
Google Scholar
Csige, I. et al. The impact of obesity on the cardiovascular system. J. Diabetes Res. 2018, 3407306 (2018).
Google Scholar
Kim, M. S. et al. Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies. Eur. Heart J. 42, 3388–3403 (2021).
Google Scholar
Kyrgiou, M. et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ 356, j477 (2017).
Google Scholar
Bhaskaran, K. et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet 384, 755–765 (2014).
Google Scholar
Petrelli, F. et al. Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis. JAMA Netw. Open 4, e213520 (2021).
Google Scholar
Leon, B. M. & Maddox, T. M. Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J. Diabetes 6, 1246–1258 (2015).
Google Scholar
Einarson, T. R. et al. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc. Diabetol. 17, 83 (2018).
Google Scholar
Raghavan, S. et al. Diabetes mellitus-related all‐cause and cardiovascular mortality in a national cohort of adults. J. Am. Heart Assoc. 8, e011295 (2019).
Google Scholar
Cai, X. et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ 370, m2297 (2020).
Google Scholar
Tsilidis, K. K. et al. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350, g7607 (2015).
Google Scholar
Ling, S. et al. Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people. Diabetes Care 43, 2313–2322 (2020).
Google Scholar
Banks, E. et al. Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study. BMC Med. 17, 128 (2019).
Google Scholar
Pan, A. et al. Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus. Circulation 132, 1795–1804 (2015).
Google Scholar
Hackshaw, A. et al. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ 360, j5855 (2018).
Google Scholar
Duncan, M. S. et al. Association of smoking cessation with subsequent risk of cardiovascular disease. JAMA 322, 642–650 (2019).
Google Scholar
Gandini, S. et al. Tobacco smoking and cancer: a meta-analysis. Int. J. Cancer 122, 155–164 (2008).
Google Scholar
Macacu, A. et al. Active and passive smoking and risk of breast cancer: a meta-analysis. Breast Cancer Res. Treat. 154, 213–224 (2015).
Google Scholar
Duan, W. et al. Smoking and survival of breast cancer patients: a meta-analysis of cohort studies. Breast 33, 117–124 (2017).
Google Scholar
Botteri, E. et al. Smoking and colorectal cancer risk, overall and by molecular subtypes: a meta-analysis. Am. J. Gastroenterol. 115, 1940–1949 (2020).
Google Scholar
O’Keeffe, L. M. et al. Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis. BMJ Open 8, e021611 (2018).
Google Scholar
Larsson, S. C. & Burgess, S. Appraising the causal role of smoking in multiple diseases: a systematic review and meta-analysis of Mendelian randomization studies. EBioMedicine 82, 104154 (2022).
Google Scholar
Zhao, J. et al. Alcohol consumption and mortality from coronary heart disease: an updated meta-analysis of cohort studies. J. Stud. Alcohol Drugs 78, 375–386 (2017).
Google Scholar
Biddinger, K. J. et al. Association of habitual alcohol intake with risk of cardiovascular disease. JAMA Netw. Open 5, e223849 (2022).
Google Scholar
Larsson, S. C. et al. Alcohol consumption and cardiovascular disease. Circ. Genom. Precis. Med. 13, e002814 (2020).
Google Scholar
Wood, A. M. et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. Lancet 391, 1513–1523 (2018).
Google Scholar
Yoo, J. E. et al. Association between changes in alcohol consumption and cancer risk. JAMA Netw. Open 5, e2228544 (2022).
Google Scholar
Bagnardi, V. et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose–response meta-analysis. Br. J. Cancer 112, 580–593 (2015).
Google Scholar
Rumgay, H. et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 22, 1071–1080 (2021).
Google Scholar
Bagnardi, V. et al. Light alcohol drinking and cancer: a meta-analysis. Ann. Oncol. 24, 301–308 (2013).
Google Scholar
Jin, M. et al. Alcohol drinking and all cancer mortality: a meta-analysis. Ann. Oncol. 24, 807–816 (2013).
Google Scholar
Martínez-González, M. A., Gea, A. & Ruiz-Canela, M. The Mediterranean diet and cardiovascular health. Circ. Res. 124, 779–798 (2019).
Google Scholar
Estruch, R. et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N. Engl. J. Med. 378, e34 (2018).
Google Scholar
Karam, G. et al. Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis. BMJ 380, e072003 (2023).
Google Scholar
Pant, A. et al. Primary prevention of cardiovascular disease in women with a Mediterranean diet: systematic review and meta-analysis. Heart 109, 1208–1215 (2023).
Google Scholar
Rodríguez-Monforte, M., Flores-Mateo, G. & Sánchez, E. Dietary patterns and CVD: a systematic review and meta-analysis of observational studies. Br. J. Nutr. 114, 1341–1359 (2015).
Google Scholar
Grosso, G. et al. A comprehensive meta-analysis on evidence of Mediterranean diet and cardiovascular disease: are individual components equal? Crit. Rev. Food Sci. Nutr. 57, 3218–3232 (2017).
Google Scholar
Miller, V. et al. Evaluation of the quality of evidence of the association of foods and nutrients with cardiovascular disease and diabetes: a systematic review. JAMA Netw. Open 5, e2146705 (2022).
Google Scholar
Bechthold, A. et al. Food groups and risk of coronary heart disease, stroke and heart failure: a systematic review and dose-response meta-analysis of prospective studies. Crit. Rev. Food Sci. Nutr. 59, 1071–1090 (2019).
Google Scholar
Gan, Z. H. et al. Association between plant-based dietary patterns and risk of cardiovascular disease: a systematic review and meta-analysis of prospective cohort studies. Nutrients 13, 3952 (2021).
Google Scholar
Quek, J. et al. The association of plant-based diet with cardiovascular disease and mortality: a meta-analysis and systematic review of prospect cohort studies. Front. Cardiovasc. Med. 8, 756810 (2021).
Google Scholar
Kim, H. et al. Plant‐based diets are associated with a lower risk of incident cardiovascular disease, cardiovascular disease mortality, and all‐cause mortality in a general population of middle‐aged adults. J. Am. Heart Assoc. 8, e012865 (2019).
Google Scholar
Thompson, A. S. et al. Association of healthful plant-based diet adherence with risk of mortality and major chronic diseases among adults in the UK. JAMA Netw. Open 6, e234714 (2023).
Google Scholar
Schwingshackl, L. et al. Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis. Nutrients 9, 1063 (2017).
Google Scholar
Morze, J. et al. An updated systematic review and meta-analysis on adherence to Mediterranean diet and risk of cancer. Eur. J. Nutr. 60, 1561–1586 (2021).
Google Scholar
Kodama, S. et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 301, 2024–2035 (2009).
Google Scholar
Sattelmair, J. et al. Dose response between physical activity and risk of coronary heart disease. Circulation 124, 789–795 (2011).
Google Scholar
Li, J. & Siegrist, J. Physical activity and risk of cardiovascular disease – a meta-analysis of prospective cohort studies. Int. J. Env. Res. Public Health 9, 391–407 (2012).
Google Scholar
Wahid, A. et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta‐analysis. J. Am. Heart Assoc. 5, e002495 (2016).
Google Scholar
Blond, K. et al. Association of high amounts of physical activity with mortality risk: a systematic review and meta-analysis. Br. J. Sports Med. 54, 1195–1201 (2020).
Google Scholar
Bailey, D. P. et al. Sitting time and risk of cardiovascular disease and diabetes: a systematic review and meta-analysis. Am. J. Prev. Med. 57, 408–416 (2019).
Google Scholar
Gonzalez-Jaramillo, N. et al. Systematic review of physical activity trajectories and mortality in patients with coronary artery disease. J. Am. Coll. Cardiol. 79, 1690–1700 (2022).
Google Scholar
Moore, S. C. et al. Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA Intern. Med. 176, 816–825 (2016).
Google Scholar
McTiernan, A. et al. Physical activity in cancer prevention and survival: a systematic review. Med. Sci. Sports Exerc. 51, 1252–1261 (2019).
Google Scholar
Friedenreich, C. M. et al. Physical activity and mortality in cancer survivors: a systematic review and meta-analysis. JNCI Cancer Spectr. 4, pkz080 (2019).
Google Scholar
Brandt, E. J. et al. Assessing and addressing social determinants of cardiovascular health: JACC state-of-the-art review. J. Am. Coll. Cardiol. 81, 1368–1385 (2023).
Google Scholar
Powell-Wiley, T. M. et al. Social determinants of cardiovascular disease. Circ. Res. 130, 782–799 (2022).
Google Scholar
Arnett, D. K. et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 140, e596–e646 (2019).
Google Scholar
Khan, S. S. et al. Development and validation of the American Heart Association’s PREVENT equations. Circulation 149, 430–449 (2024).
Google Scholar
Howard, V. J. et al. The Reasons for Geographic and Racial Differences in Stroke study: objectives and design. Neuroepidemiology 25, 135–143 (2005).
Google Scholar
Sterling, M. R. et al. Social determinants of health and 90‐day mortality after hospitalization for heart failure in the REGARDS study. J. Am. Heart Assoc. 9, e014836 (2020).
Google Scholar
Safford, M. M. et al. Number of social determinants of health and fatal and nonfatal incident coronary heart disease in the REGARDS study. Circulation 143, 244–253 (2021).
Google Scholar
Reshetnyak, E. et al. Impact of multiple social determinants of health on incident stroke. Stroke 51, 2445–2453 (2020).
Google Scholar
Pinheiro, L. C. et al. Social determinants of health and cancer mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study. Cancer 128, 122–130 (2022).
Google Scholar
Ganatra, S. et al. Impact of social vulnerability on comorbid cancer and cardiovascular disease mortality in the United States. JACC CardioOncol. 4, 326–337 (2022).
Google Scholar
Tufano, A., Coppola, A. & Galderisi, M. The growing impact of cardiovascular oncology: epidemiology and pathophysiology. Semin. Thromb. Hemost. 47, 899–906 (2021).
Google Scholar
Lenihan, D. J. & Cardinale, D. M. Late cardiac effects of cancer treatment. J. Clin. Oncol. 30, 3657–3664 (2012).
Google Scholar
van Dorst, D. C. H. et al. Hypertension and prohypertensive antineoplastic therapies in cancer patients. Circ. Res. 128, 1040–1061 (2021).
Google Scholar
Sturgeon, K. M. et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur. Heart J. 40, 3889–3897 (2019).
Google Scholar
Yang, H. et al. The role of genetic predisposition in cardiovascular risk after cancer diagnosis: a matched cohort study of the UK Biobank. Br. J. Cancer 127, 1650–1659 (2022).
Google Scholar
Zaorsky, N. G. et al. Causes of death among cancer patients. Ann. Oncol. 28, 400–407 (2017).
Google Scholar
Zullig, L. L. et al. Cardiometabolic comorbidities in cancer survivors. JACC CardioOncol. 4, 149–165 (2022).
Google Scholar
Sloten, T. V. et al. Association of midlife cardiovascular health and subsequent change in cardiovascular health with incident cancer. JACC CardioOncol. 5, 39–52 (2023).
Google Scholar
Yun, J. P. et al. Risk of atrial fibrillation according to cancer type. JACC CardioOncol. 3, 221–232 (2021).
Google Scholar
Raisi-Estabragh, Z. et al. Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer. Heart 109, 1007–1015 (2023).
Google Scholar
Meacham, L. R. et al. Cardiovascular risk factors in adult survivors of pediatric cancer – a report from the Childhood Cancer Survivor study. Cancer Epidemiol. Biomark. Prev. 19, 170–181 (2010).
Google Scholar
Hasin, T. et al. Patients with heart failure have an increased risk of incident cancer. J. Am. Coll. Cardiol. 62, 881–886 (2013).
Google Scholar
Hasin, T. et al. Heart failure after myocardial infarction is associated with increased risk of cancer. J. Am. Coll. Cardiol. 68, 265–271 (2016).
Google Scholar
Banke, A. et al. Incidence of cancer in patients with chronic heart failure: a long-term follow-up study. Eur. J. Heart Fail. 18, 260–266 (2016).
Google Scholar
Suzuki, M. et al. Incidence of cancers in patients with atherosclerotic cardiovascular diseases. Int. J. Cardiol. Heart Vasc. 17, 11–16 (2017).
Google Scholar
Lau, E. S. et al. Cardiovascular risk factors are associated with future cancer. JACC CardioOncol. 3, 48–58 (2021).
Google Scholar
Meijers, W. C. et al. Heart failure stimulates tumor growth by circulating factors. Circulation 138, 678–691 (2018).
Google Scholar
Carpeggiani, C. et al. Stress echocardiography positivity predicts cancer death. J. Am. Heart Assoc. 6, e007104 (2017).
Google Scholar
Selvaraj, S. et al. Lack of association between heart failure and incident cancer. J. Am. Coll. Cardiol. 71, 1501–1510 (2018).
Google Scholar
Lam, P. H. et al. Temporal associations and outcomes of breast cancer and heart failure in postmenopausal women. JACC CardioOncol. 2, 567–577 (2020).
Google Scholar
Leedy, D. J. et al. The association between heart failure and incident cancer in women: an analysis of the Women’s Health Initiative. Eur. J. Heart Fail. 23, 1712–1721 (2021).
Google Scholar
Libby, P. & Kobold, S. Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology. Cardiovasc. Res. 115, 824–829 (2019).
Google Scholar
Mehdizadeh, M. et al. The role of cellular senescence in cardiac disease: basic biology and clinical relevance. Nat. Rev. Cardiol. 19, 250–264 (2022).
Google Scholar
Schmitt, C. A., Wang, B. & Demaria, M. Senescence and cancer – role and therapeutic opportunities. Nat. Rev. Clin. Oncol. 19, 619–636 (2022).
Google Scholar
Ferrucci, L. & Fabbri, E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat. Rev. Cardiol. 15, 505–522 (2018).
Google Scholar
Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 25, 1822–1832 (2019).
Google Scholar
Kong, P. et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct. Target. Ther. 7, 131 (2022).
Google Scholar
Soehnlein, O. & Libby, P. Targeting inflammation in atherosclerosis – from experimental insights to the clinic. Nat. Rev. Drug Discov. 20, 589–610 (2021).
Google Scholar
Engelen, S. E. et al. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nat. Rev. Cardiol. 19, 522–542 (2022).
Google Scholar
Jin, C., Henao-Mejia, J. & Flavell, R. A. Innate immune receptors: key regulators of metabolic disease progression. Cell Metab. 17, 873–882 (2013).
Google Scholar
Hotamisligil, G. S. Inflammation, metaflammation and immunometabolic disorders. Nature 542, 177–185 (2017).
Google Scholar
Zhao, H. et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct. Target. Ther. 6, 263 (2021).
Google Scholar
Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, Inflammation, and cancer. Cell 140, 883–899 (2010).
Google Scholar
Taniguchi, K. & Karin, M. NF-κB, inflammation, immunity and cancer: coming of age. Nat. Rev. Immunol. 18, 309–324 (2018).
Google Scholar
Münzel, T. et al. Impact of oxidative stress on the heart and vasculature: part 2 of a 3-part series. J. Am. Coll. Cardiol. 70, 212–229 (2017).
Google Scholar
Peoples, J. N. et al. Mitochondrial dysfunction and oxidative stress in heart disease. Exp. Mol. Med. 51, 1–13 (2019).
Google Scholar
Forman, H. J. & Zhang, H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 20, 689–709 (2021).
Google Scholar
Sack, M. N. et al. Basic biology of oxidative stress and the cardiovascular system. J. Am. Coll. Cardiol. 70, 196–211 (2017).
Google Scholar
Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. Oxidative stress in cancer. Cancer Cell 38, 167–197 (2020).
Google Scholar
Perillo, B. et al. ROS in cancer therapy: the bright side of the moon. Exp. Mol. Med. 52, 192–203 (2020).
Google Scholar
Jaiswal, S. Clonal hematopoiesis and nonhematologic disorders. Blood 136, 1606–1614 (2020).
Google Scholar
Yura, Y., Cochran, J. D. & Walsh, K. Therapy-related clonal hematopoiesis: a new link between cancer and cardiovascular disease. Heart Fail. Clin. 18, 349–359 (2022).
Google Scholar
Marnell, C. S., Bick, A. & Natarajan, P. Clonal hematopoiesis of indeterminate potential (CHIP): linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease. J. Mol. Cell. Cardiol. 161, 98–105 (2021).
Google Scholar
Calvillo-Arguelles, O. et al. Connections between clonal hematopoiesis, cardiovascular disease, and cancer: a review. JAMA Cardiol. 4, 380–387 (2019).
Google Scholar
Fuster, J. J. Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors. Thromb. Res. 213, S107–S112 (2022).
Google Scholar
Jaiswal, S. & Ebert, B. L. Clonal hematopoiesis in human aging and disease. Science 366, eaan4673 (2019).
Google Scholar
Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488–2498 (2014).
Google Scholar
Jaiswal, S. et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N. Engl. J. Med. 377, 111–121 (2017).
Google Scholar
Coombs, C. C. et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 21, 374–382 (2017).
Google Scholar
Calvillo-Argüelles, O. et al. Cardiovascular disease among patients with AML and CHIP-related mutations. JACC CardioOncol. 4, 38–49 (2022).
Google Scholar
Trøseid, M. et al. The gut microbiome in coronary artery disease and heart failure: current knowledge and future directions. EBioMedicine 52, 102649 (2020).
Google Scholar
Masenga, S. K. et al. Recent advances in modulation of cardiovascular diseases by the gut microbiota. J. Hum. Hypertens. 36, 952–959 (2022).
Google Scholar
Park, E. M. et al. Targeting the gut and tumor microbiota in cancer. Nat. Med. 28, 690–703 (2022).
Google Scholar
Witkowski, M., Weeks, T. L. & Hazen, S. L. Gut microbiota and cardiovascular disease. Circ. Res. 127, 553–570 (2020).
Google Scholar
Chakaroun, R. M., Olsson, L. M. & Bäckhed, F. The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease. Nat. Rev. Cardiol. 20, 217–235 (2023).
Google Scholar
Tang, W. H. W., Kitai, T. & Hazen, S. L. Gut microbiota in cardiovascular health and disease. Circ. Res. 120, 1183–1196 (2017).
Google Scholar
Rahman, M. M. et al. Microbiome in cancer: role in carcinogenesis and impact in therapeutic strategies. Biomed. Pharmacother. 149, 112898 (2022).
Google Scholar
Wong, C. C. & Yu, J. Gut microbiota in colorectal cancer development and therapy. Nat. Rev. Clin. Oncol. 20, 429–452 (2023).
Google Scholar
Ağagündüz, D. et al. Understanding the role of the gut microbiome in gastrointestinal cancer: a review. Front. Pharmacol. 14, 1130562 (2023).
Google Scholar
Zhao, L.-Y. et al. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduct. Target. Ther. 8, 201 (2023).
Google Scholar
Vujkovic-Cvijin, I. et al. Host variables confound gut microbiota studies of human disease. Nature 587, 448–454 (2020).
Google Scholar
Avraham, S. et al. Early cardiac remodeling promotes tumor growth and metastasis. Circulation 142, 670–683 (2020).
Google Scholar
Tani, T. et al. Heart failure post myocardial infarction promotes mammary tumor growth through the NGF-TRKA pathway. JACC CardioOncol. 6, 55–66 (2024).
Google Scholar
Porporato, P. E. et al. Mitochondrial metabolism and cancer. Cell Res. 28, 265–280 (2018).
Google Scholar
Karlstaedt, A. et al. Cardio-oncology. JACC Basic Transl. Sci. 6, 705–718 (2021).
Google Scholar
Huang, W. et al. Cellular senescence: the good, the bad and the unknown. Nat. Rev. Nephrol. 18, 611–627 (2022).
Google Scholar
Wilcox, N. S. et al. Sex-specific cardiovascular risks of cancer and its therapies. Circ. Res. 130, 632–651 (2022).
Google Scholar
Okwuosa, T. M. et al. Impact of hormonal therapies for treatment of hormone-dependent cancers (breast and prostate) on the cardiovascular system: effects and modifications: a scientific statement from the American Heart Association. Circ. Genom. Precis. Med. 14, e000082 (2021).
Google Scholar
Noyd, D. H. et al. Cardiovascular risk factor disparities in adult survivors of childhood cancer compared with the general population. JACC CardioOncol. 5, 489–500 (2023).
Google Scholar
American Cancer Society. Cancer treatment & survivorship facts & figures 2022-2024 (American Cancer Society, 2022).
Handy, C. E. et al. Synergistic opportunities in the interplay between cancer screening and cardiovascular disease risk assessment: together we are stronger. Circulation 138, 727–734 (2018).
Google Scholar
Fradley, M. G. et al. Developing a clinical cardio-oncology program and the building blocks for success. JACC CardioOncol. 5, 707–710 (2023).
Google Scholar
Liu, E. E. et al. Association of cardiometabolic disease with cancer in the community. JACC CardioOncol. 4, 69–81 (2022).
Google Scholar
Salloum, F. N. et al. Priorities in cardio-oncology basic and translational science. JACC CardioOncol. 5, 715–731 (2023).
Google Scholar
